» Articles » PMID: 35263592

Mutant CHCHD10 Causes an Extensive Metabolic Rewiring That Precedes OXPHOS Dysfunction in a Murine Model of Mitochondrial Cardiomyopathy

Overview
Journal Cell Rep
Publisher Cell Press
Date 2022 Mar 9
PMID 35263592
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondrial cardiomyopathies are fatal diseases, with no effective treatment. Alterations of heart mitochondrial function activate the mitochondrial integrated stress response (ISR), a transcriptional program affecting cell metabolism, mitochondrial biogenesis, and proteostasis. In humans, mutations in CHCHD10, a mitochondrial protein with unknown function, were recently associated with dominant multi-system mitochondrial diseases, whose pathogenic mechanisms remain to be elucidated. Here, in CHCHD10 knockin mutant mice, we identify an extensive cardiac metabolic rewiring triggered by proteotoxic ISR. The stress response arises early on, before the onset of bioenergetic impairments, triggering a switch from oxidative to glycolytic metabolism, enhancement of transsulfuration and one carbon (1C) metabolism, and widespread metabolic imbalance. In parallel, increased NADPH oxidases elicit antioxidant responses, leading to heme depletion. As the disease progresses, the adaptive metabolic stress response fails, resulting in fatal cardiomyopathy. Our findings suggest that early interventions to counteract metabolic imbalance could ameliorate mitochondrial cardiomyopathy associated with proteotoxic ISR.

Citing Articles

Dysregulation of mitochondrial α-ketoglutarate dehydrogenase leads to elevated lipid peroxidation in CHCHD2-linked Parkinson's disease models.

Gao G, Shi Y, Deng H, Krainc D Nat Commun. 2025; 16(1):1982.

PMID: 40011434 PMC: 11865444. DOI: 10.1038/s41467-025-57142-9.


NADH-bound AIF activates the mitochondrial CHCHD4/MIA40 chaperone by a substrate-mimicry mechanism.

Brosey C, Shen R, Tainer J EMBO J. 2025; 44(4):1220-1248.

PMID: 39806100 PMC: 11832770. DOI: 10.1038/s44318-024-00360-6.


CHCHD2 mutant mice display mitochondrial protein accumulation and disrupted energy metabolism.

Liao S, Kano K, Phanse S, Nguyen M, Margolis E, Fu Y bioRxiv. 2024; .

PMID: 39257750 PMC: 11384018. DOI: 10.1101/2024.08.30.610586.


CHCHD2 P14L, found in amyotrophic lateral sclerosis, exhibits cytoplasmic mislocalization and alters Ca homeostasis.

Ikeda A, Meng H, Taniguchi D, Mio M, Funayama M, Nishioka K PNAS Nexus. 2024; 3(8):pgae319.

PMID: 39131911 PMC: 11316225. DOI: 10.1093/pnasnexus/pgae319.


High fat diet ameliorates mitochondrial cardiomyopathy in CHCHD10 mutant mice.

Southwell N, Manzo O, Bacman S, Zhao D, Sayles N, Dash J EMBO Mol Med. 2024; 16(6):1352-1378.

PMID: 38724625 PMC: 11178915. DOI: 10.1038/s44321-024-00067-5.


References
1.
Bertero E, Maack C . Metabolic remodelling in heart failure. Nat Rev Cardiol. 2018; 15(8):457-470. DOI: 10.1038/s41569-018-0044-6. View

2.
Tran D, Wang Z . Glucose Metabolism in Cardiac Hypertrophy and Heart Failure. J Am Heart Assoc. 2019; 8(12):e012673. PMC: 6645632. DOI: 10.1161/JAHA.119.012673. View

3.
Chen E, Tan C, Kou Y, Duan Q, Wang Z, Meirelles G . Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013; 14:128. PMC: 3637064. DOI: 10.1186/1471-2105-14-128. View

4.
Xu J, Kimball T, Lorenz J, Brown D, Bauskin A, Klevitsky R . GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circ Res. 2006; 98(3):342-50. DOI: 10.1161/01.RES.0000202804.84885.d0. View

5.
Khan N, Nikkanen J, Yatsuga S, Jackson C, Wang L, Pradhan S . mTORC1 Regulates Mitochondrial Integrated Stress Response and Mitochondrial Myopathy Progression. Cell Metab. 2017; 26(2):419-428.e5. DOI: 10.1016/j.cmet.2017.07.007. View